Ionis Pharmaceuticals, Inc.
Selective Antisense Compounds and Uses Thereof
Last updated:
Abstract:
The present invention provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.
Status:
Application
Type:
Utility
Filling date:
30 Jun 2020
Issue date:
20 May 2021